| abstract |
A pharmaceutical composition characterized in that an antibody-drug conjugate, in which a drug linker represented by the formula (wherein A represents an antibody binding site) is bonded to an antibody via a thioether bond, is combined with a PARP inhibitor and administered, and/or a therapeutic method characterized in that the antibody-drug conjugate is combined with a PARP inhibitor and administered to an individual. |